H - Index
In this guide
In this guideOn this page
Skip the menu of subheadings on this page.|
Subject: Health and Safety Executive (HSE) |
Year |
Page |
|
Work of, presentation to COM on |
2021 |
63 |
|
Subject: Health effects in populations living close to landfill sites |
Year |
Page |
|
Negative birth outcomes and cancer |
2000 |
19 |
|
Landfill sites |
2001 |
11 |
|
COT statement on, consideration of SAHSU study |
2001 |
12 |
|
Subject: Heat-not-burn tobacco products and their safety overview of genotoxicity data submitted (confidential) |
Year |
Page |
|
Assessment of the toxicological risks from novel heat-not-burn tobacco products |
2017 |
8, 51 |
|
Kl’Assessment of the toxicological risks from novel heat-not-burn tobacco products |
2017 |
41 |
|
Subject: Hemicellulase |
Year |
Page |
|
Hemicellulase Enzyme in bread-making |
1999 |
19 |
|
From Aspergillus niger |
1994 |
8 |
|
Hemicellulase, preparations of |
1995 |
9 |
|
Hemicellulase |
1996 |
9 |
|
Subject: Hexachlorobutadiene contamination at Weston Quarries |
Year |
Page |
|
In Cheshire, mutagenicity |
2000 |
20 |
|
Hexachlorobutadiene, new data considerations |
2003 |
10 |
Subject:Hexabromocyclododecanes in the infant diet |
Year |
Page |
|
possible health risks from the exposure of infants to HBCDDs in breast milk, dust and food |
2014 |
12 |
|
Estimated exposures, margin of exposure |
2015 |
7 |
|
and young children |
2016 |
11kl |
|
Subject: Hexachlorocyclohexanes in the infant diet |
Year |
Page |
|
α-, β- and γ-hexachlorocyclohexanes |
2003 |
10 |
|
Subject: Histamine |
Year |
Page |
|
In food |
2016 |
12 |
|
Subject: Hormesis |
Year |
Page |
|
The occurrence of “U” shaped dose dose-response curves |
2003 |
196 |
|
in Mutagenicity Dose-Response Relationships |
2012 |
38 |
|
Subject: Hydrocarbon propellants |
Year |
Page |
|
Safety of |
1994 |
9 |
|
Subject: Hydroquinone and phenol |
Year |
Page |
|
interpretation of the mutagenicity data on |
1994 |
20 |
|
metabolism of hydroquinone and phenolic derivatives in the lung and skin |
1995 |
34 |
|
COM re-evaluation, inhalation and dermal exposure |
2000 |
60 |
|
review of mutagenicity of Aclonifen and risk assessments of its postulated metabolites |
2008 |
262 |
Subject:Hydroxyanthracene derivatives (HADs) |
Year |
Page |
|
COM evaluation of |
2021 |
62 |
|
Subject: Hyperactivity |
Year |
Page |
|
Hyperactive children’s support group |
1996 |
9 |
|
Hyperactivity and food additives |
2000 |
27 |